Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Completed 2Suspended 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Cancer Pain 2Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Mucositis 1Chronic Pain 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Buprenorphine × Clear all
NCT04752384 2025-04-20

Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients

Medical College of Wisconsin

Phase 2 Completed
20 enrolled 10 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Mucositis

NCT01809106 2015-12-24

CERP

Mario Negri Institute for Pharmacological Research

Phase 4 Completed
518 enrolled 11 charts

Cancer Pain, Neoplasms

NCT00916890 2014-01-09

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 4 Suspended
320 enrolled

Cancer Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡